Quarterly report pursuant to Section 13 or 15(d)

Net Income/(Loss) per Common Share (Tables)

v3.22.4
Net Income/(Loss) per Common Share (Tables)
 9 Months Ended
Dec. 31, 2022
Earnings Per Share [Abstract]  
Schedule of reconciliation of the denominators used to calculate basic EPS and diluted EPS
The reconciliations of the denominators used to calculate basic and diluted net income/(loss) per common share for the three and nine months ended December 31, 2022 and 2021, respectively, are as follows:
 Three Months Ended December 31, 2022  Three Months Ended December 31, 2021 Nine Months Ended December 31, 2022 Nine Months Ended December 31, 2021
Basic net income/(loss) per common share    
Net income/(loss) $ 8,425  $ 11,270  $ 25,965  $ 11,407 
Weighted-average common shares outstanding 33,493,540  33,340,000  33,457,048  33,292,614 
Basic net income/(loss) per common share $ 0.25  $ 0.34  $ 0.78  $ 0.34 
Three Months Ended December 31, 2022 Three Months Ended December 31, 2021 Nine Months Ended December 31, 2022 Nine Months Ended December 31, 2021
Diluted net income/(loss) per common share    
Net income/(loss) $ 8,425  $ 11,270  $ 25,965  $ 11,407 
Weighted-average common shares outstanding 33,493,540  33,340,000  33,457,048  33,292,614 
Common share equivalents:
Stock options 7,858  271  2,545  1,660 
Restricted and performance stock units 378,335  317,833  296,625  187,690 
Weighted average shares outstanding – dilutive (1)
33,879,733  33,658,104  33,756,218  33,481,964 
Diluted net income/(loss) per common share $ 0.25  $ 0.33  $ 0.77  $ 0.34 
(1) For the three months ended December 31, 2022 and 2021, 28,499 and 45,099 equity awards, respectively and for the nine months ended December 31, 2022 and 2021, 39,517 and 139,843 equity awards, respectively, were not included in the calculation of diluted net income/(loss) per common share, as they would have had an anti-dilutive effect.